A Study of CS-3150 to Evaluate Efficacy and Safety to in combination with ARB or ACE inhibitor in Hypertensive Patients with Moderate Renal Impairment
Phase of Trial: Phase III
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Esaxerenone (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 01 Aug 2017 Status changed from active, no longer recruiting to completed.
- 15 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Jun 2016 Status changed from not yet recruiting to recruiting.